| Model: | Ratio |
| Symbol | Title | Sector | Industry | M.Cap.[M] | Div Yield | Last Close | AvgVol 200d |
| GSK | GlaxoSmithKline PLC ADR | Healthcare | Drug Manufacturers - General | 107812 | 0.0332 | 53.77 | 5042888 |
| NVS | Novartis AG ADR | Healthcare | Drug Manufacturers - General | 299375 | 0.0306 | 154.87 | 1779863 |
| Entry Threshold: | 2.00 | Exit Threshold: | 0.00 | ||
| Max Duration: | 20 | Entry Mode: | Uptick | Reversals: | |
| MA Period: | 15 | MA Type: | EMA | StdDev Period: | 15 |
| RSI Period: | 14 | RSI Threshold: | 0 | ||
| Margin Req. 1: | 50.0 | Margin Req. 2: | 50.0 | ||
| Version: | 5 | Model Version: | 2016.1 | Bid-Ask 0.01 / 0.01 | |
| Initial Capital: | 10000.00 | Final Equity: | 10137.76 |
| Total net P/L: | 137.76 | Total ROI: | 1.38 % |
| CAGR: | 8.68 % | Max. DD: | 1.59 % |
| System Score: | 2.374 | Sharpe Ratio: | 0.426 |
| Start Date: | 2010-04-01 | End Date: | 2010-05-31 |
| Total days: | 60 | ||
| Commissions: | 15.64 | Comm.% P/L | 10.20 % |
| Total Transactions: | 12 | Log. Linearity: | 64.910 % |
| Total | Long |
Short |
GSK | NVS | |
|---|---|---|---|---|---|
| Total Profit/Loss | 153.40 | 155.91 | -2.51 | 672.48 | -519.08 |
| Total Profit | 161.82 | 155.91 | 5.91 | 672.48 | 24.35 |
| Total Loss | 8.42 | 0.00 | 8.42 | 0.00 | 543.43 |
| Profit Factor | 19.23 | 0.00 | 0.70 | 0.00 | 0.04 |
| Trades | 3 | 1 | 2 | 3 | 3 |
| Winning Trades | 2 | 1 | 1 | 3 | 1 |
| Losing Trades | 1 | 0 | 1 | 0 | 2 |
| % Profitable | 66.00 | 100.00 | 50.00 | 100.00 | 33.00 |
| Profit/Loss Per Trade % | 0.51 | 1.56 | -0.01 | 2.23 | -1.73 |
| Profit Per Trade % | 0.81 | 1.56 | 0.06 | 2.23 | 0.24 |
| Loss Per Trade % | 0.08 | 0.00 | 0.08 | 0.00 | 2.70 |
| Days In Trade | 38 | 5 | 33 | 38 | 38 |
| Days In Trade (Avg. Per Trade) | 12.67 | 5.00 | 16.50 | 12.67 | 12.67 |
| % Days In Trade | 63.33 | 8.33 | 55.00 | 63.33 | 63.33 |